14-ene-202276002CaliValle37femeninocontributivootro3-ene-202229-dic-202129-nov-202129-nov-2021silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 25-ene-202276002CaliValle40femeninosubsidiadootro14-dic-202115-ago-20216-oct-20227-oct-2022sicarcinoma escamocelularinfiltrantesipositivoin-situ2023-03-27T00:00:0015-abr-2023 34-ene-202276002CaliValle62femeninocontributivootro3-ene-202226-jun-202124-jun-202124-jun-2021sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 49-ene-202276003CaliValle42femeninosubsidiadootro9-ene-202221-sep-202117-dic-202121-dic-2021sicarcinoma escamocelularin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 512-ene-202276004CaliValle53femeninosubsidiadootro12-ene-202227-sep-20217-dic-202120-dic-2021silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 619-ene-202276005CaliValle54femeninosubsidiadootro14-ene-202217-dic-202127-dic-20213-ene-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 719-ene-202276006CaliValle49femeninosubsidiadootro19-ene-202219-ene-202219-ene-202225-ene-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 818-ene-202276007CaliValle40femeninosubsidiadootro18-ene-202218-ene-202218-ene-202221-ene-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 921-ene-202276008CaliValle47femeninosubsidiadootro20-ene-202220-ago-202120-ago-202120-ago-2021sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 1019-ene-202276009CaliValle33femeninosubsidiadootro19-ene-20227-oct-202117-dic-202127-dic-2021silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 1125-ene-202276010CaliValle69femeninocontributivootro24-ene-20221-oct-202123-dic-202123-dic-2021no#N/A#N/Asipositivoin-situ2023-03-27T00:00:0015-abr-2023 1228-ene-202276011CaliValle23femeninosubsidiadootro28-ene-202228-sep-202118-ene-202225-ene-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1328-ene-202276012CaliValle32femeninosubsidiadootro27-ene-202229-nov-202114-dic-202120-dic-2021silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1428-ene-202276013CaliValle36femeninosubsidiadootro27-ene-202210-nov-202114-dic-202120-dic-2021sicarcinoma escamocelularno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 1526-ene-202276014CaliValle27femeninocontributivootro25-ene-20227-sep-202126-oct-202126-oct-2021sicarcinoma escamocelularin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 1627-ene-202276015CaliValle48femeninosubsidiadootro27-ene-202227-ene-202227-ene-20223-feb-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 1726-ene-202276016CaliValle36femeninosubsidiadootro26-ene-202220-dic-202120-dic-202128-dic-2021sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 1831-ene-202276017CaliValle23femeninosubsidiadootro28-ene-20222-oct-202126-oct-20213-nov-2021silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 193-feb-202276018CaliValle59femeninosubsidiadootro3-feb-20223-feb-20223-feb-20227-mar-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 204-feb-202276019CaliValle42femeninosubsidiadoafrocolombiano4-feb-202225-ene-202221-ene-202225-ene-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 212-feb-202276020CaliValle70femeninosubsidiadootro2-feb-20222-feb-20222-feb-20224-feb-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 223-feb-202276021CaliValle44femeninosubsidiadootro7-ene-202217-dic-202118-ene-202225-ene-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 233-feb-202276022CaliValle32femeninosubsidiadootro3-feb-20226-oct-202111-ene-202219-ene-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 243-feb-202276023CaliValle38femeninosubsidiadootro3-feb-20223-feb-20223-feb-20227-feb-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 2511-feb-202276024CaliValle47femeninosubsidiadootro11-feb-202222-dic-202122-dic-20213-feb-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 2611-feb-202276025CaliValle50femeninosubsidiadootro10-feb-202226-nov-202125-ene-202227-ene-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 2711-feb-202276026CaliValle30femeninosubsidiadootro11-feb-202220-oct-20211-feb-20223-feb-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 287-feb-202276027CaliValle30femeninocontributivootro5-feb-202220-ene-202220-ene-202220-ene-2022no#N/A#N/Ano#N/A#N/A2023-03-27T00:00:0015-abr-2023 2911-feb-202276028CaliValle51femeninosubsidiadootro4-feb-20224-feb-20213-nov-202120-nov-2021sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 3010-feb-202276029CaliValle63femeninosubsidiadootro9-feb-202214-ene-202221-ene-202221-ene-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 319-feb-202276030CaliValle47femeninono afiliadootro7-feb-202224-ene-202224-ene-20227-feb-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 329-feb-202276031CaliValle29femeninosubsidiadootro7-feb-202224-ene-20222-feb-20227-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 3310-feb-202276032CaliValle33femeninosubsidiadootro26-ene-20223-nov-20211-feb-20224-feb-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 3410-feb-202276033CaliValle39femeninosubsidiadootro13-ene-202215-dic-202118-ene-202225-ene-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 3514-feb-202276034CaliValle34femeninocontributivootro14-feb-202214-feb-202214-feb-202222-mar-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 3615-feb-202276035CaliValle78femeninoexcepcionotro27-oct-202121-jul-202121-jul-202123-sep-2021no#N/A#N/Asipositivono indicado2023-03-27T00:00:0015-abr-2023 3718-feb-202276036CaliValle42femeninocontributivootro21-ene-20221-ene-202227-ene-202227-ene-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 3817-feb-202276037CaliValle56femeninocontributivootro16-feb-202216-nov-202128-ene-202228-ene-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 3917-feb-202276038CaliValle36femeninosubsidiadootro17-feb-202217-ago-202123-nov-20216-dic-2021sicarcinoma escamocelularin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 4018-feb-202276039CaliValle24femeninocontributivootro27-ene-20221-ene-202227-ene-20226-feb-2022silei-agno indicadosipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 4118-feb-202276040CaliValle39femeninocontributivoafrocolombiano10-feb-20221-ene-202210-feb-202210-feb-2022sicarcinoma escamocelularno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 4225-feb-202276041CaliValle39femeninocontributivootro24-feb-202211-oct-202120-ene-202220-ene-2022sicarcinoma escamocelularin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 4324-feb-202276042CaliValle27femeninosubsidiadoraizal 24-feb-202219-ene-20228-feb-202215-feb-2022silei-agin-situsipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 4423-feb-202276043CaliValle53femeninosubsidiadootro23-feb-202219-ene-20228-feb-202215-feb-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 4524-feb-202276044CaliValle30femeninosubsidiadootro24-feb-202213-ene-20228-feb-202215-feb-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 463-mar-202276045CaliValle44femeninocontributivootro1-mar-20221-ene-202128-feb-202228-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 472-mar-202276046CaliValle36femeninosubsidiadootro1-mar-20222-feb-202217-nov-202117-nov-2021sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 4812-mar-202276047CaliValle87femeninocontributivootro10-ene-20229-ene-202231-ene-20229-feb-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 497-mar-202276048CaliValle33femeninocontributivootro5-mar-202226-oct-202127-ene-202227-ene-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 509-mar-202276049CaliValle41femeninocontributivootro2-mar-20222-ene-20222-mar-20228-mar-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 518-mar-202276050CaliValle36femeninosubsidiadootro24-ene-202224-ene-202224-ene-202227-ene-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 5212-mar-202276051CaliValle54femeninosubsidiadootro9-mar-202231-ene-202216-feb-202217-feb-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 538-mar-202276052CaliValle33femeninosubsidiadootro31-ene-202231-ene-202231-ene-20223-feb-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 5410-mar-202276053CaliValle59femeninosubsidiadootro10-mar-202210-mar-202210-mar-202214-mar-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 559-mar-202276054CaliValle53femeninocontributivootro8-mar-20228-mar-202216-feb-202216-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 5610-mar-202276055CaliValle31femeninosubsidiadootro10-feb-202210-feb-202215-feb-202221-feb-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 5712-mar-202276056CaliValle56femeninosubsidiadootro2-feb-202212-dic-20214-feb-20223-mar-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 5817-mar-202276057CaliValle25femeninocontributivootro15-feb-202215-feb-20223-mar-202210-mar-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 5916-mar-202276058CaliValle39femeninocontributivootro15-mar-202231-ene-202225-feb-202225-feb-2022sicarcinoma escamocelularno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 6018-mar-202276059CaliValle83femeninosubsidiadootro17-mar-202224-nov-202115-feb-202217-feb-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 6117-mar-202276060CaliValle80femeninocontributivootro30-mar-202128-mar-20216-abr-202112-abr-2021no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 6219-mar-202276061CaliValle37femeninosubsidiadootro3-nov-20213-nov-20213-nov-20219-nov-2021silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 6319-mar-202276062CaliValle30femeninosubsidiadootro21-dic-202121-dic-202121-dic-202121-dic-2021silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 6415-mar-202276063CaliValle57femeninosubsidiadootro9-feb-20229-feb-20229-feb-202215-feb-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 6519-mar-202276064CaliValle31femeninosubsidiadootro26-ene-202226-ene-202226-ene-20221-feb-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 6617-mar-202276065CaliValle41femeninosubsidiadootro17-mar-202217-mar-202217-mar-202222-mar-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 6715-mar-202276066CaliValle44femeninocontributivootro14-mar-20228-mar-20228-mar-20228-mar-2022no#N/A#N/Ano#N/A#N/A2023-03-27T00:00:0015-abr-2023 6817-mar-202276067CaliValle49femeninosubsidiadootro7-ene-20227-ene-202215-feb-202218-feb-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 6926-mar-202276068CaliValle68femeninosubsidiadootro10-mar-202223-feb-202215-mar-202218-mar-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 7025-mar-202276069CaliValle36femeninocontributivootro23-mar-20222-feb-20222-feb-202214-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 7126-mar-202276070CaliValle69femeninosubsidiadootro14-mar-20227-sep-202115-mar-202218-mar-2022no#N/A#N/Asipositivoin-situ2023-03-27T00:00:0015-abr-2023 7224-mar-202276071CaliValle53femeninocontributivootro9-mar-20229-mar-20229-mar-202227-abr-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 7326-mar-202276072CaliValle20femeninocontributivoafrocolombiano3-mar-20221-ene-20223-mar-20228-mar-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 741-abr-202276073CaliValle32femeninosubsidiadootro3-feb-20223-feb-20223-feb-20227-feb-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 7529-mar-202276074CaliValle34femeninocontributivootro26-may-20212-mar-20219-abr-202117-abr-2021sicarcinoma escamocelularin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 761-abr-202276075CaliValle26femeninosubsidiadootro28-feb-202228-feb-202228-feb-20222-mar-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 7731-mar-202276076CaliValle45femeninocontributivootro30-mar-202229-may-20213-feb-20223-feb-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 781-abr-202276077CaliValle31femeninosubsidiadootro6-dic-20216-dic-20216-dic-202110-dic-2021silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 7931-mar-202276078CaliValle44femeninosubsidiadootro31-mar-202231-mar-202231-mar-20224-abr-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 8030-mar-202276079CaliValle27femeninosubsidiadootro30-mar-202230-mar-202230-mar-20224-abr-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 8128-mar-202276080CaliValle53femeninosubsidiadootro11-feb-202211-feb-202211-feb-202217-feb-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 821-abr-202276081CaliValle51femeninosubsidiadootro1-abr-20221-abr-202211-may-202213-may-2022sicarcinoma escamocelularin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 8328-mar-202276082CaliValle47femeninosubsidiadootro23-dic-202123-dic-202123-dic-202130-dic-2021silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 8428-mar-202276083CaliValle62femeninoexcepcionotro28-mar-20229-dic-202116-mar-202222-mar-2022sicarcinoma escamocelularno indicadosipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 851-abr-202276084CaliValle31femeninocontributivootro31-mar-202218-ene-202126-feb-202226-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 864-abr-202276085CaliValle69femeninosubsidiadootro1-abr-20221-abr-20221-abr-20226-abr-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 877-abr-202276086CaliValle31femeninosubsidiadootro7-abr-20227-abr-20227-abr-20229-abr-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 888-abr-202276087CaliValle40femeninosubsidiadootro8-abr-202217-mar-202224-mar-202231-mar-2022sicarcinoma escamocelularin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 896-abr-202276088CaliValle34femeninocontributivootro5-abr-20225-ene-202225-mar-202225-mar-2022no#N/A#N/Asipositivono indicado2023-03-27T00:00:0015-abr-2023 9014-abr-202276089CaliValle50femeninosubsidiadootro13-abr-202229-dic-202124-ene-202224-ene-2022sicarcinoma escamocelularno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 9111-abr-202276090CaliValle30femeninocontributivootro8-abr-202216-mar-202218-mar-202218-mar-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 9212-abr-202276091CaliValle42femeninoexcepcionotro9-jun-202117-ene-202118-jun-202125-jun-2021no#N/A#N/Asinegativo#N/A2023-03-27T00:00:0015-abr-2023 9311-abr-202276092CaliValle39femeninoexcepcionotro18-feb-202223-ago-20213-nov-20219-nov-2021no#N/A#N/Asipositivoin-situ2023-03-27T00:00:0015-abr-2023 9416-abr-202276093CaliValle58femeninosubsidiadootro7-feb-202215-nov-202114-mar-202228-mar-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 9521-abr-202276094CaliValle32femeninosubsidiadootro16-mar-202216-mar-202229-mar-20225-abr-2022sicarcinoma escamocelularin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 9623-abr-202276095CaliValle37femeninosubsidiadootro21-abr-202221-abr-202221-abr-202227-abr-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 9722-abr-202276096CaliValle28femeninosubsidiadootro22-abr-202222-abr-202222-abr-202227-abr-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 9823-abr-202276097CaliValle58femeninosubsidiadootro10-mar-202210-dic-202123-mar-202229-mar-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 9930-abr-202276098CaliValle41femeninocontributivootro9-abr-20221-feb-20229-abr-202213-abr-2022sicarcinoma escamocelularno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 10030-abr-202276099CaliValle65femeninosubsidiadootro23-mar-20221-feb-202223-mar-202227-mar-2022sicarcinoma escamocelularno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 10130-abr-202276100CaliValle28femeninocontributivootro2-abr-20221-feb-20222-abr-20226-abr-2022sicarcinoma escamocelularno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 10228-abr-202276101CaliValle41femeninosubsidiadootro28-abr-202228-abr-202228-abr-20223-may-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 10328-abr-202276102CaliValle91femeninosubsidiadootro28-abr-202228-abr-202228-abr-202230-abr-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 10428-abr-202276103CaliValle33femeninocontributivootro27-abr-202217-nov-202030-mar-202230-mar-2022no#N/A#N/Asipositivono indicado2023-03-27T00:00:0015-abr-2023 10529-abr-202276104CaliValle47femeninocontributivootro11-mar-20222-feb-202229-mar-20225-abr-2022no#N/A#N/Asipositivono indicado2023-03-27T00:00:0015-abr-2023 10629-abr-202276105CaliValle30femeninosubsidiadootro29-mar-202211-mar-20225-abr-20228-abr-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 10726-abr-202276106CaliValle27femeninocontributivootro6-abr-20226-mar-20226-abr-202222-abr-2022sicarcinoma escamocelularno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 1081-may-202276107CaliValle43femeninocontributivootro28-feb-202225-ene-202228-ene-202215-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 1093-may-202276108CaliValle43femeninocontributivootro2-may-202210-mar-202112-abr-202212-abr-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 1102-may-202276109CaliValle39femeninocontributivootro29-abr-202225-mar-202225-mar-202225-mar-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 1112-may-202276110CaliValle44femeninosubsidiadootro29-abr-202226-ene-202219-abr-202220-abr-2022silei-agin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 1121-may-202276111CaliValle34femeninocontributivootro4-mar-202210-feb-202211-feb-202225-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 1136-may-202276112CaliValle33femeninosubsidiadootro22-dic-202122-dic-202122-dic-202124-dic-2021silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1146-may-202276113CaliValle38femeninosubsidiadootro6-may-20224-may-20224-may-20226-may-2022silei-agno indicadosipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 1155-may-202276114CaliValle38femeninocontributivootro4-may-202212-abr-202212-abr-202212-abr-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 1162-may-202276115CaliValle41femeninosubsidiadootro5-abr-20225-abr-20227-abr-202211-abr-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 11711-may-202276116CaliValle38femeninono afiliadootro11-may-202211-may-202211-may-202216-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 11810-may-202276117CaliValle29femeninosubsidiadootro10-may-202210-may-202210-may-202213-may-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 11911-may-202276118CaliValle34femeninosubsidiadootro11-may-202211-may-202211-may-202216-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1209-may-202276119CaliValle46femeninosubsidiadootro9-may-20229-may-20229-may-202211-may-2022silei-agno indicadosipositivoin-situ2023-03-27T00:00:0015-abr-2023 12110-may-202276120CaliValle27femeninosubsidiadootro10-may-202210-may-202210-may-202212-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 12219-may-202276121CaliValle31femeninosubsidiadootro2-feb-202227-ene-202226-abr-202210-may-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 12316-may-202276122CaliValle41femeninosubsidiadootro13-may-202213-may-20227-abr-20227-abr-2022silei-agno indicadosipositivoin-situ2023-03-27T00:00:0015-abr-2023 12416-may-202276123CaliValle31femeninocontributivootro16-may-202216-may-202216-may-202219-may-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 12519-may-202276124CaliValle41femeninosubsidiadootro19-may-202219-may-202219-may-202223-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 12619-may-202276125CaliValle24femeninosubsidiadootro19-may-202219-may-202219-may-202223-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 12716-may-202276126CaliValle37femeninocontributivootro25-abr-202225-abr-202228-abr-202211-may-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 12818-may-202276127CaliValle69femeninosubsidiadootro18-may-202218-may-202218-may-202223-may-2022silei-agno indicadosipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 12921-may-202276128CaliValle53femeninosubsidiadootro19-mar-202210-oct-202130-mar-20225-abr-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 13018-may-202276129CaliValle64femeninosubsidiadootro4-abr-20224-abr-20224-abr-20227-abr-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 13116-may-202276130CaliValle36femeninocontributivootro13-may-20221-mar-202214-mar-202214-mar-2022no#N/A#N/Ano#N/A#N/A2023-03-27T00:00:0015-abr-2023 13224-may-202276131CaliValle55femeninocontributivootro23-may-20229-feb-202226-abr-20227-may-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 13327-may-202276132CaliValle38femeninosubsidiadootro27-may-202227-may-202227-may-20222-jun-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 13428-may-202276133CaliValle48femeninosubsidiadootro27-may-202227-may-202227-may-20222-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 13522-may-202276134CaliValle40femeninocontributivootro26-abr-202226-ene-202226-abr-202217-may-2022sicarcinoma escamocelularno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 13628-may-202276135CaliValle48femeninocontributivootro11-may-20221-ene-202211-may-202216-may-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 13727-may-202276136CaliValle28femeninosubsidiadootro29-abr-202229-abr-202217-may-202220-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 13827-may-202276137CaliValle27femeninosubsidiadootro9-may-20229-may-202217-may-202220-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 13926-may-202276138CaliValle40femeninosubsidiadootro2-may-20226-abr-20223-may-202210-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 14023-may-202276139CaliValle29femeninocontributivootro18-mar-202218-mar-202228-sep-202110-feb-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 14127-may-202276140CaliValle38femeninosubsidiadootro9-may-20229-may-202217-may-202220-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 14226-may-202276141CaliValle55femeninosubsidiadootro24-may-202224-mar-202224-mar-202224-mar-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 14328-may-202276142CaliValle39femeninocontributivootro21-abr-20221-ene-202224-abr-202229-abr-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 14431-may-202276143CaliValle51femeninosubsidiadootro4-feb-202210-sep-202112-ene-202231-ene-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 14531-may-202276144CaliValle56femeninosubsidiadootro8-mar-202210-ene-202221-ene-20227-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 14631-may-202276145CaliValle42femeninocontributivootro2-mar-202218-feb-202218-feb-202218-feb-2022no#N/A#N/Ano#N/A#N/A2023-03-27T00:00:0015-abr-2023 14731-may-202276146CaliValle32femeninosubsidiadootro27-may-202222-abr-202217-may-202217-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 14831-may-202276147CaliValle43femeninocontributivootro2-feb-202210-feb-20215-ene-202220-ene-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 1493-jun-202276148CaliValle39femeninosubsidiadootro3-jun-202224-may-202224-may-202224-may-2022silei-agin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 15031-may-202276149CaliValle44femeninocontributivootro31-may-202231-may-202231-may-20222-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1511-jun-202276150CaliValle35femeninosubsidiadootro1-jun-20221-jun-20221-jun-20227-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 15231-may-202276151CaliValle24femeninocontributivootro31-may-202231-may-202231-may-20226-jun-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 1532-jun-202276152CaliValle67femeninosubsidiadootro1-jun-20221-jun-20221-jun-20221-jun-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 1543-jun-202276153CaliValle75femeninosubsidiadootro19-mar-20226-feb-202215-feb-202215-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 1559-jun-202276154CaliValle36femeninosubsidiadootro19-may-202219-may-202224-may-202227-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1569-jun-202276155CaliValle28femeninocontributivootro27-abr-202227-abr-202231-mar-202220-abr-2022sicarcinoma escamocelularin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 1576-jun-202276156CaliValle60femeninosubsidiadootro6-jun-20226-jun-20226-jun-20228-jun-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 1588-jun-202276157CaliValle45femeninocontributivootro7-jun-20221-jun-202017-may-202217-may-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 1598-jun-202276158CaliValle56femeninosubsidiadootro2-jun-202227-abr-202227-may-20222-jun-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 1606-jun-202276159CaliValle35femeninocontributivootro6-jun-20226-jun-20226-jun-20228-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1618-jun-202276160CaliValle51femeninosubsidiadootro8-jun-20225-ene-20225-may-202219-may-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 1627-jun-202276161CaliValle32femeninosubsidiadootro19-may-202219-may-202224-may-202227-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1637-jun-202276162CaliValle62femeninosubsidiadootro29-mar-202229-mar-20223-may-202210-may-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 16414-jun-202276163CaliValle47femeninosubsidiadootro13-jun-202213-jun-202213-jun-202215-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 16513-jun-202276164CaliValle31femeninosubsidiadootro13-jun-202213-jun-202213-jun-202215-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 16614-jun-202276165CaliValle46femeninosubsidiadootro14-jun-202214-jun-202214-jun-202216-jun-2022silei-agin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 16714-jun-202276166CaliValle66femeninocontributivootro14-jun-202213-abr-20221-jun-202211-jun-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 16817-jun-202276167CaliValle32femeninocontributivootro15-jun-202231-mar-20222-jun-20228-jun-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 16918-jun-202276168CaliValle74femeninosubsidiadootro4-abr-20221-mar-20224-jun-20229-jun-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 17022-jun-202276169CaliValle33femeninocontributivootro22-jun-202226-may-202226-may-202222-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 17121-jun-202276170CaliValle37femeninosubsidiadootro17-jun-202219-may-20227-jun-202210-jun-2022silei-agin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 17221-jun-202276171CaliValle32femeninosubsidiadootro17-jun-202210-may-20227-jun-202210-jun-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 17322-jun-202276172CaliValle63femeninocontributivootro25-may-202225-may-20225-may-202211-may-2022#N/A#N/Ainfiltrantesi#N/A#N/A2023-03-27T00:00:0015-abr-2023 17424-jun-202276173CaliValle45femeninosubsidiadootro23-jun-20221-ene-202217-may-202218-may-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 17522-jun-202276174CaliValle57femeninosubsidiadootro21-jun-202221-jun-202221-jun-202224-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 17623-jun-202276175CaliValle26femeninosubsidiadootro22-jun-202222-jun-202222-jun-202222-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 17723-jun-202276176CaliValle32femeninosubsidiadootro22-jun-202222-jun-202222-jun-202228-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 17829-jun-202276177CaliValle53femeninosubsidiadootro28-jun-202228-jun-202228-jun-20225-jul-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 17929-jun-202276178CaliValle26femeninosubsidiadootro23-jun-202219-may-202214-jun-202217-jun-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 1801-jul-202276179CaliValle49femeninosubsidiadootro30-jun-202230-jun-202230-jun-20226-jul-2022silei-agin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 18129-jun-202276180CaliValle44femeninosubsidiadootro23-jun-202220-may-202220-may-202217-jun-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 18230-jun-202276181CaliValle31femeninosubsidiadootro29-jun-202229-jun-202229-jun-20226-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 1831-jul-202276182CaliValle67femeninocontributivootro24-jun-202211-may-202211-may-202211-may-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 18430-jun-202276183CaliValle60femeninosubsidiadootro29-jun-202229-jun-202229-jun-20226-jul-2022sicarcinoma escamocelularno indicadosipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 1851-jul-202276184CaliValle30femeninocontributivootro24-jun-202217-jun-20222-feb-20222-feb-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 1867-jul-202276185CaliValle66femeninosubsidiadootro6-jul-20226-jul-20226-jul-202212-jul-2022silei-agin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 1879-jul-202276186CaliValle52femeninosubsidiadootro8-jul-20228-jul-20228-jul-202212-jul-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 1889-jul-202276187CaliValle35femeninosubsidiadootro8-jul-20228-jul-20228-jul-202213-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 18913-jul-202276188CaliValle30femeninosubsidiadootro22-jun-202222-jun-202228-jun-20226-jul-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 19015-jul-202276189CaliValle69femeninosubsidiadootro15-jul-202229-mar-202222-mar-202229-mar-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 19114-jul-202276190CaliValle35femeninosubsidiadootro13-jul-202213-jun-202213-jun-202215-jun-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 19215-jul-202276191CaliValle63femeninosubsidiadootro14-jul-202214-jul-202214-jul-202219-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 19313-jul-202276192CaliValle39femeninosubsidiadootro13-jul-202223-jun-202229-jun-202212-jul-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 19414-jul-202276193CaliValle63femeninocontributivootro13-jul-202224-may-202224-jun-202230-jun-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 19515-jul-202276194CaliValle44femeninocontributivootro15-jun-202220-abr-202215-jun-20222-jul-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 19622-jul-202276195CaliValle37femeninosubsidiadootro21-jul-202225-jun-202226-ago-20221-sep-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 19720-jul-202276196CaliValle33femeninosubsidiadootro19-jul-202219-jul-202226-ago-202230-ago-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 19822-jul-202276197CaliValle28femeninosubsidiadootro21-jul-202221-jul-202221-jul-202225-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 19925-jul-202276198CaliValle40femeninocontributivootro15-jun-202215-jun-202226-may-202226-may-2022si#N/A#N/Asipositivoin-situ2023-03-27T00:00:0015-abr-2023 20026-jul-202276199CaliValle39femeninocontributivootro25-jul-202225-jul-202225-jul-202228-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 20126-jul-202276200CaliValle31femeninosubsidiadootro25-jul-202225-jul-202225-jul-202228-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 20229-jul-202276201CaliValle69femeninosubsidiadootro28-jul-202228-jul-202228-jul-20221-ago-2022sicarcinoma escamocelularno indicadosipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 2034-ago-202276202CaliValle50femeninosubsidiadootro27-may-20222-ene-202211-may-202229-may-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 2044-ago-202276203CaliValle43femeninocontributivootro9-mar-20221-ene-20228-feb-202228-feb-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 2052-ago-202276204CaliValle55femeninocontributivootro17-feb-20225-ene-20225-ene-202220-ene-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 2064-ago-202276205CaliValle36femeninosubsidiadootro3-ago-20223-ago-20223-ago-20229-ago-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 2071-ago-202276206CaliValle43femeninocontributivootro29-jul-20221-jun-20225-jul-20225-jul-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 2088-ago-202276207CaliValle25femeninosubsidiadootro5-ago-202213-jul-202226-jul-202228-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 20920-ago-202276208CaliValle31femeninosubsidiadootro17-ago-20221-ene-202213-jul-202219-jul-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 21020-ago-202276209CaliValle36femeninocontributivootro17-ago-20221-ene-202215-jul-202215-jul-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 21117-ago-202276210CaliValle61femeninosubsidiadootro3-ago-20223-ago-20229-ago-202212-ago-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 21220-ago-202276211CaliValle38femeninosubsidiadoafrocolombiano17-ago-20221-ene-202217-ago-202220-ago-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 21320-ago-202276212CaliValle35femeninocontributivootro19-ago-20221-ene-20229-jun-202215-jun-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 21420-ago-202276213CaliValle29femeninocontributivootro8-ago-20221-ene-20228-ago-201111-ago-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 21520-ago-202276214CaliValle27femeninocontributivootro19-ago-20221-ene-202219-ago-202220-ago-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 21618-ago-202276215CaliValle43femeninosubsidiadootro13-ago-202222-jul-202227-jul-20222-ago-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 21720-ago-202276216CaliValle32femeninocontributivootro18-ago-20221-ene-202224-jun-20222-jul-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 21817-ago-202276217CaliValle31femeninosubsidiadootro1-jul-202214-jun-202226-jul-20223-ago-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 21920-ago-202276218CaliValle35femeninocontributivootro18-ago-20221-ene-202218-ago-202220-ago-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 22018-ago-202276219CaliValle59femeninosubsidiadootro26-jul-20223-jun-20225-jun-202211-jul-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 22117-ago-202276220CaliValle43femeninosubsidiadootro12-ago-202221-jul-20221-jul-20228-jul-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 22220-ago-202276221CaliValle35femeninosubsidiadootro18-ago-20221-ene-202226-may-20223-jun-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 22320-ago-202276222CaliValle38femeninocontributivootro8-ago-20221-ene-20228-ago-202212-ago-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 22420-ago-202276223CaliValle44femeninocontributivootro18-ago-20221-ene-202222-may-20223-jun-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 22522-ago-202276224CaliValle28femeninocontributivootro18-ago-202211-jun-20224-ago-202216-ago-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 22622-ago-202276225CaliValle42femeninocontributivootro19-ago-202219-may-202230-jun-202230-jun-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 22729-ago-202276226CaliValle39femeninocontributivootro26-ago-202230-dic-202121-jun-202221-jun-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 22831-ago-202276227CaliValle36femeninocontributivootro31-ago-202225-ago-202225-ago-202231-ago-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 22931-ago-202276228CaliValle65femeninocontributivootro30-ago-20221-mar-20225-ago-202216-ago-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 23029-ago-202276229CaliValle23femeninosubsidiadootro12-ago-20225-ago-202216-ago-202222-ago-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 23131-ago-202276230CaliValle30femeninocontributivootro30-ago-202230-mar-20228-ago-20228-ago-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 23210-sep-202276231CaliValle30femeninosubsidiadootro9-sep-202214-jun-202214-jun-202217-jun-2022silei-agno indicadosipositivoin-situ2023-03-27T00:00:0015-abr-2023 2336-sep-202276232CaliValle40femeninosubsidiadorom 18-ago-20221-ene-202218-ago-202222-ago-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 23410-sep-202276233CaliValle24femeninosubsidiadootro10-sep-20229-sep-202222-jul-202226-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 23510-sep-202276234CaliValle30femeninosubsidiadootro9-sep-20229-sep-202213-jul-202218-jul-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 23610-sep-202276235CaliValle24femeninosubsidiadootro9-sep-20222-sep-202214-jul-202219-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 23710-sep-202276236CaliValle38femeninosubsidiadootro9-sep-202214-jul-202214-jul-202221-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 2389-sep-202276237CaliValle32femeninosubsidiadootro22-ago-202214-jul-202223-ago-202229-ago-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 2399-sep-202276238CaliValle32femeninosubsidiadootro22-ago-202214-jul-202223-ago-202229-ago-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 24015-sep-202276239CaliValle32femeninosubsidiadootro22-jun-202227-may-202223-ago-202229-ago-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 24112-sep-202276240CaliValle80femeninocontributivootro12-sep-20225-feb-202225-ago-202225-ago-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 24215-sep-202276241CaliValle39femeninosubsidiadootro14-sep-202214-sep-202225-jul-202228-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 24315-sep-202276242CaliValle44femeninosubsidiadootro5-jul-20225-jul-202223-ago-202229-ago-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 24423-sep-202276243CaliValle34femeninosubsidiadootro21-sep-202221-sep-20228-jul-202211-jul-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 24521-sep-202276244CaliValle53femeninocontributivootro20-sep-20221-ene-20183-sep-20223-sep-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 24623-sep-202276245CaliValle71femeninocontributivootro14-jun-202214-may-202219-jul-20228-ago-2022no#N/A#N/Asipositivono indicado2023-03-27T00:00:0015-abr-2023 24729-sep-202276246CaliValle37femeninoexcepcionotro30-mar-20221-ene-202213-dic-202113-dic-2021no#N/A#N/Asipositivono indicado2023-03-27T00:00:0015-abr-2023 24827-sep-202276247CaliValle42femeninosubsidiadootro27-sep-202227-sep-202220-ene-20236-feb-2023silei-agno indicadosipositivoin-situ2023-03-27T00:00:0015-abr-2023 24928-sep-202276248CaliValle28femeninocontributivootro27-sep-20221-ene-20196-sep-202212-sep-2022no#N/A#N/Asipositivoin-situ2023-03-27T00:00:0015-abr-2023 25029-sep-202276249CaliValle55femeninoexcepcionotro22-abr-20221-ene-202218-mar-202218-mar-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 2516-oct-202276250CaliValle57femeninocontributivootro5-oct-20221-sep-202223-sep-202230-sep-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 2525-oct-202276251CaliValle55femeninocontributivootro3-oct-20221-abr-202213-sep-202213-sep-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 2538-oct-202276252CaliValle65femeninosubsidiadootro7-oct-20227-oct-202224-jun-20225-jul-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 2548-oct-202276253CaliValle52femeninosubsidiadootro7-oct-20227-oct-20222-ago-20229-ago-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 2556-oct-202276254CaliValle63femeninosubsidiadootro3-oct-20225-jul-202219-sep-202219-sep-2022no#N/A#N/Asinegativo#N/A2023-03-27T00:00:0015-abr-2023 2567-oct-202276255CaliValle48femeninocontributivootro5-oct-20221-dic-202130-sep-202230-sep-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 2579-oct-202276256CaliValle65femeninosubsidiadootro8-oct-20228-oct-202211-oct-202212-oct-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 25814-oct-202276257CaliValle62femeninosubsidiadootro12-oct-202212-oct-202223-ago-202227-ago-2022silei-agno indicadosipositivoin-situ2023-03-27T00:00:0015-abr-2023 25914-oct-202276258CaliValle51femeninosubsidiadootro14-oct-202214-oct-202231-ago-20227-sep-2022sicarcinoma escamocelularin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 2609-oct-202276259CaliValle61femeninosubsidiadootro8-oct-20228-oct-20226-sep-20229-sep-2022silei-agno indicadosipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 26114-oct-202276260CaliValle41femeninosubsidiadootro12-oct-202212-oct-202216-ago-202218-ago-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 26214-oct-202276261CaliValle67femeninosubsidiadootro13-oct-202213-oct-20226-sep-20229-sep-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 2639-oct-202276262CaliValle35femeninosubsidiadootro8-oct-20228-oct-202213-oct-202213-oct-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 2649-oct-202276263CaliValle33femeninosubsidiadootro8-oct-20228-oct-202216-ago-20228-oct-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 2659-oct-202276264CaliValle35femeninosubsidiadootro8-oct-20228-oct-20227-sep-20229-oct-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 26612-oct-202276265CaliValle36femeninocontributivootro11-oct-20221-feb-202223-sep-202223-sep-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 2679-oct-202276266CaliValle42femeninosubsidiadootro8-oct-20228-oct-20226-sep-20225-oct-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 26814-oct-202276267CaliValle29femeninosubsidiadootro12-oct-202212-oct-202223-ago-202226-ago-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 2699-oct-202276268CaliValle38femeninosubsidiadootro8-oct-20228-oct-202218-jul-202221-jul-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 2709-oct-202276269CaliValle26femeninosubsidiadootro8-oct-20228-oct-202231-ago-20221-sep-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 27113-oct-202276270CaliValle51femeninocontributivootro10-oct-202222-mar-20225-oct-202210-oct-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 27213-oct-202276271CaliValle47femeninocontributivootro12-oct-20221-jun-202219-sep-202219-sep-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 27313-oct-202276272CaliValle39femeninocontributivootro7-oct-20227-oct-202220-sep-202226-sep-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 27420-oct-202276273CaliValle31femeninosubsidiadootro19-oct-202219-oct-202226-jul-202228-jul-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 27518-oct-202276274CaliValle45femeninocontributivootro14-oct-202225-mar-202225-mar-202218-abr-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 27626-oct-202276275CaliValle55femeninocontributivootro3-ene-20221-ene-20195-ago-202111-ago-2021sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 27724-oct-202276276CaliValle56femeninocontributivootro12-ago-20223-mar-20228-abr-20225-may-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 27824-oct-202276277CaliValle57femeninocontributivootro22-oct-20222-ago-202214-oct-202222-oct-2022no#N/A#N/Asipositivoin-situ2023-03-27T00:00:0015-abr-2023 27925-oct-202276278CaliValle48femeninosubsidiadootro8-sep-20225-sep-20228-sep-202213-sep-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 28025-oct-202276279CaliValle35femeninocontributivootro4-mar-202221-feb-202221-feb-202210-mar-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 28124-oct-202276280CaliValle46femeninosubsidiadootro9-sep-20223-abr-202211-jul-202225-jul-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 28228-oct-202276281CaliValle31femeninocontributivootro18-oct-202210-oct-202218-oct-202225-oct-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 28325-oct-202276282CaliValle47femeninocontributivootro24-oct-20221-feb-20228-sep-20228-sep-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 28426-oct-202276283CaliValle66femeninosubsidiadootro4-ene-20224-ene-202110-feb-202116-feb-2021sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 28525-oct-202276284CaliValle53femeninocontributivootro20-ene-202220-ene-201929-oct-20215-nov-2021sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 28627-oct-202276285CaliValle30femeninocontributivootro13-sep-202213-sep-202213-sep-202215-sep-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 28727-oct-202276286CaliValle36femeninocontributivootro21-sep-202221-sep-202221-sep-202226-sep-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 28826-oct-202276287CaliValle52femeninosubsidiadootro5-ene-202211-may-202026-jul-20212-ago-2021sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 28926-oct-202276288CaliValle45femeninosubsidiadootro22-oct-202215-feb-202222-ago-20229-sep-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 29026-oct-202276289CaliValle33femeninocontributivootro26-oct-20221-jul-202118-oct-202222-oct-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 29125-oct-202276290CaliValle56femeninocontributivootro19-ene-202219-may-202131-ago-20215-sep-2021sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 29225-oct-202276291CaliValle80femeninono afiliadootro13-ene-202213-sep-202121-sep-202126-sep-2021sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 29325-oct-202276292CaliValle42femeninocontributivootro4-oct-202222-sep-20225-oct-202211-oct-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 29425-oct-202276293CaliValle25femeninocontributivootro29-sep-202225-sep-202226-sep-202228-sep-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 29524-oct-202276294CaliValle34femeninocontributivootro11-sep-20224-sep-202216-sep-202216-sep-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 29631-oct-202276295CaliValle63femeninocontributivootro31-oct-202231-ago-202217-nov-202217-nov-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 29731-oct-202276296CaliValle67femeninocontributivootro22-feb-202220-ene-20229-feb-202224-feb-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 2981-nov-202276297CaliValle53femeninono afiliadootro31-oct-202213-oct-202213-oct-202213-oct-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 2993-nov-202276298CaliValle33femeninosubsidiadootro27-sep-202212-sep-202218-oct-202224-oct-2022sicarcinoma escamocelularin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 3003-nov-202276299CaliValle30femeninocontributivootro1-sep-202228-mar-202227-ago-202213-sep-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 3013-nov-202276300CaliValle41femeninosubsidiadootro4-oct-20229-ago-20226-oct-20227-oct-2022sicarcinoma escamocelularin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 3023-nov-202276301CaliValle26femeninosubsidiadootro4-oct-202223-ago-20224-oct-20227-oct-2022sicarcinoma escamocelularin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 3034-nov-202276302CaliValle33femeninocontributivootro3-nov-202211-oct-202211-oct-202211-oct-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 30411-nov-202276303CaliValle48femeninosubsidiadootro11-nov-202211-nov-202227-sep-202230-sep-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 30511-nov-202276304CaliValle29femeninosubsidiadootro11-nov-202211-nov-202227-oct-202228-oct-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 30619-nov-202276305CaliValle39femeninocontributivootro19-nov-202219-nov-202225-oct-202226-oct-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 30719-nov-202276306CaliValle40femeninocontributivootro19-nov-202219-nov-20222-may-20224-may-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 30819-nov-202276307CaliValle41femeninosubsidiadootro19-nov-202219-nov-20221-nov-20222-nov-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 30919-nov-202276308CaliValle27femeninosubsidiadootro19-nov-202219-nov-202227-oct-202231-oct-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 31019-nov-202276309CaliValle33femeninosubsidiadootro19-nov-202219-nov-202225-oct-202227-oct-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 31119-nov-202276310CaliValle29femeninosubsidiadootro19-nov-202219-nov-202222-ago-202224-ago-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 31219-nov-202276311CaliValle28femeninosubsidiadootro19-nov-202219-nov-202225-oct-202226-oct-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 31319-nov-202276312CaliValle23femeninosubsidiadootro19-nov-202219-nov-20224-oct-20227-oct-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 31419-nov-202276313CaliValle32femeninosubsidiadootro19-nov-202219-nov-202227-oct-202231-oct-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 31519-nov-202276314CaliValle40femeninosubsidiadootro19-nov-202219-nov-202227-oct-202231-oct-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 31619-nov-202276315CaliValle36femeninosubsidiadootro19-nov-202219-nov-202218-oct-202220-oct-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 31716-nov-202276316CaliValle41femeninosubsidiadootro16-nov-202216-nov-202213-oct-202221-oct-2022no#N/A#N/Asipositivono indicado2023-03-27T00:00:0015-abr-2023 31824-nov-202276317CaliValle50femeninocontributivootro14-oct-202224-dic-202124-dic-202131-ene-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 31923-nov-202276318CaliValle28femeninocontributivootro15-sep-202211-jun-202211-jun-202223-jun-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 32024-nov-202276319CaliValle46femeninocontributivootro1-oct-202210-jun-202210-jun-202222-jun-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 32124-nov-202276320CaliValle29femeninocontributivootro23-nov-20221-jul-202210-nov-202210-nov-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 32220-nov-202276321CaliValle45femeninocontributivootro14-jun-20222-mar-202216-may-20224-jun-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 32329-nov-202276322CaliValle58femeninocontributivootro19-abr-20221-abr-202216-jun-202211-jul-2022sicarcinoma escamocelularinfiltrantesinegativo#N/A2023-03-27T00:00:0015-abr-2023 32430-nov-202276323CaliValle35femeninocontributivootro29-nov-20221-abr-202210-nov-202210-nov-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 32528-nov-202276324CaliValle33femeninocontributivootro24-nov-202218-nov-202211-nov-202218-nov-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 32630-nov-202276325CaliValle43femeninocontributivootro11-jul-202214-jun-202230-jul-202217-ago-2022no#N/A#N/Asipositivoin-situ2023-03-27T00:00:0015-abr-2023 32730-nov-202276326CaliValle44femeninocontributivootro9-jun-202228-ene-202229-jul-202217-ago-2022silei-agno indicadosipositivoin-situ2023-03-27T00:00:0015-abr-2023 32830-nov-202276327CaliValle45femeninosubsidiadootro29-jun-202228-feb-20226-jun-20228-jun-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 32930-nov-202276328CaliValle39femeninocontributivootro13-jul-202221-jun-202229-jul-202217-ago-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 33029-nov-202276329CaliValle73femeninocontributivootro16-abr-20221-dic-20215-may-202219-may-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 33129-nov-202276330CaliValle78femeninocontributivootro16-mar-20221-ene-20227-may-202212-may-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 3321-dic-202276331CaliValle52femeninocontributivootro7-oct-20221-ago-202216-sep-202228-sep-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 3332-dic-202276332CaliValle37femeninocontributivootro4-oct-202224-abr-202217-sep-202229-sep-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 33428-nov-202276333CaliValle38femeninocontributivootro24-nov-202221-oct-202221-oct-202221-oct-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 33530-nov-202276334CaliValle49femeninocontributivootro6-jul-202227-abr-202223-jul-20229-ago-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 33630-nov-202276335CaliValle46femeninocontributivootro24-ago-20227-dic-202122-jul-202218-ago-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 3371-dic-202276336CaliValle32femeninocontributivootro8-jun-202218-may-202220-ago-20222-sep-2022silei-agin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 33830-nov-202276337CaliValle20femeninocontributivootro30-jun-202228-abr-20225-ago-202218-ago-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 3391-dic-202276338CaliValle29femeninocontributivootro31-ago-20224-may-20223-sep-202213-sep-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 34030-nov-202276339CaliValle31femeninocontributivootro12-jul-20221-jun-202222-jul-202218-ago-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 34129-nov-202276340CaliValle27femeninocontributivootro27-abr-20222-nov-202120-may-202213-jun-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 34230-nov-202276341CaliValle38femeninocontributivootro1-jun-202217-may-202223-jul-20226-ago-2022sicarcinoma escamocelularin-situsipositivono indicado2023-03-27T00:00:0015-abr-2023 34329-nov-202276342CaliValle30femeninocontributivootro22-mar-20221-oct-20213-may-20225-may-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 3441-dic-202276343CaliValle34femeninocontributivootro21-jul-202223-jun-202222-ago-20222-sep-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 3451-dic-202276344CaliValle30femeninocontributivootro7-sep-202213-jul-202223-ago-20222-sep-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 3461-dic-202276345CaliValle38femeninocontributivootro29-sep-20221-sep-202212-sep-202225-sep-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 3471-dic-202276346CaliValle32femeninocontributivootro30-jul-202222-jul-202217-sep-202229-sep-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 3481-dic-202276347CaliValle24femeninocontributivootro12-jul-202217-jun-20222-sep-202212-sep-2022silei-agno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 34929-nov-202276348CaliValle63femeninocontributivootro6-sep-20222-feb-202220-ago-20224-sep-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 35028-nov-202276349CaliValle52femeninocontributivootro5-sep-20223-ene-202211-jul-202221-jul-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 35130-nov-202276350CaliValle50femeninosubsidiadootro25-jul-202225-oct-20218-dic-202120-ene-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 3525-dic-202276351CaliValle34femeninocontributivootro5-dic-202225-nov-202225-nov-20225-dic-2022silei-agno indicadosipositivono indicado2023-03-27T00:00:0015-abr-2023 3535-dic-202276352CaliValle27femeninocontributivootro5-dic-202225-nov-202225-nov-20225-dic-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 35414-dic-202276353CaliValle56femeninosubsidiadootro17-ago-20228-jul-202225-oct-202228-nov-2022silei-agin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 35514-dic-202276354CaliValle58femeninosubsidiadootro31-ago-20228-ago-20221-nov-202228-nov-2022sicarcinoma escamocelularin-situsipositivoin-situ2023-03-27T00:00:0015-abr-2023 35614-dic-202276355CaliValle60femeninosubsidiadootro26-oct-20227-oct-20221-nov-202228-nov-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 35712-dic-202276356CaliValle27femeninocontributivootro1-dic-20222-nov-20222-nov-202211-nov-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 35814-dic-202276357CaliValle32femeninosubsidiadootro24-oct-20226-oct-20224-nov-202228-nov-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 35912-dic-202276358CaliValle28femeninosubsidiadootro19-sep-20223-sep-202228-oct-20223-nov-2022silei-agno indicadosinegativo#N/A2023-03-27T00:00:0015-abr-2023 36014-dic-202276359CaliValle30femeninosubsidiadootro21-oct-20223-oct-20221-nov-202228-nov-2022silei-agin-situsinegativo#N/A2023-03-27T00:00:0015-abr-2023 36116-dic-202276360CaliValle48femeninocontributivoafrocolombiano7-dic-20227-sep-202210-nov-202217-nov-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 36219-dic-202276361CaliValle56femeninoexcepcionotro19-dic-20229-dic-20222-dic-20227-dic-2022sicarcinoma escamocelularinfiltrantesipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 36321-dic-202276362CaliValle68femeninocontributivootro20-dic-20221-sep-202214-dic-202214-dic-2022no#N/A#N/Asipositivono indicado2023-03-27T00:00:0015-abr-2023 36421-dic-202276363CaliValle37femeninocontributivootro20-dic-202212-ago-202228-nov-202228-nov-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023 36529-dic-202276364CaliValle48femeninosubsidiadootro28-dic-20221-oct-202221-dic-202221-dic-2022no#N/A#N/Asipositivoinfiltrante2023-03-27T00:00:0015-abr-2023 36627-dic-202276365CaliValle40femeninocontributivootro26-dic-20221-sep-20224-dic-20226-dic-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 36731-dic-202276366CaliValle77femeninocontributivootro31-dic-202222-ago-20228-sep-202214-sep-2022sicarcinoma escamocelularinfiltranteno#N/A#N/A2023-03-27T00:00:0015-abr-2023 36831-dic-202276367CaliValle50femeninocontributivootro18-oct-20221-ene-20223-nov-202217-nov-2022sicarcinoma escamocelularno indicadono#N/A#N/A2023-03-27T00:00:0015-abr-2023 36929-dic-202276368CaliValle58femeninosubsidiadoafrocolombiano2-dic-20222-ago-202218-nov-202228-nov-2022sicarcinoma escamocelularin-situno#N/A#N/A2023-03-27T00:00:0015-abr-2023